Abstract: It is intended to find novel pharmaceutical use of sphingomyelin and to provide preventive or therapeutic agents for various diseases as well as a food and drink product and feed comprising any of these agents. The present invention provides a pharmaceutical agent which contains sphingomyelin as an active ingredient and is any of the following agents: 1) a sialomucin secretion promoter, 2) an agent for preventing drunken sickness (hangover), 3) an antiallergic agent, 4) an antioxidant, 5) an agent for defending against infection, 6) a hair growth agent, 7) a therapeutic agent for demyelinating disease, 8) an anti-pigmentation agent, 9) an anti-inflammatory agent, and 10) an agent for improving learning ability. The present invention also provides a food and drink product or feed, characterized by comprising the agent. It is preferred that the sphingomyelin should be derived from milk.

Abstract: Manufacture a powder with high milk-derived complex lipid content that contains milk-derived phospholipids and milk-derived ganglioside at high concentrations, which contains protein by 15 to 35 percent by dry weight and fat by 45 to 60 percent by dry weight, wherein the content of milk-derived complex lipids is 20 percent by dry weight or more, and which can be utilized as a material for functional food, mother's milk substitute or drug, by means of adjusting the pH value of a butter serum or butter serum powder reconstituted liquid to a range of 4.0 to 5.0, adding calcium chloride to promote coagulation of protein, removing the produced sediments, filtering the supernatant by means of ultrafiltration or microfiltration, and then drying the obtained concentrate.

Abstract: To provide a fat accumulation inhibitor and a food or drink for inhibiting fat accumulation, a visceral fat accumulation inhibitor and a food or drink for inhibiting visceral fat accumulation, or an agent for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood and a food or drink for accelerating increase and/or inhibiting decrease of an adiponectin concentration in blood. A fat accumulation inhibitor for a fat cell, which comprises a milk-derived phospholipid as an active ingredient, and a food or drink for inhibiting fat accumulation in a fat cell, which comprises a milk-derived phospholipid. A visceral fat accumulation inhibitor comprising a sphingosine-containing phospholipid or a derivative thereof as an active ingredient, and a food or drink for inhibiting visceral fat accumulation.

Abstract: A skin beautifier contains sphingomyelin, which is a phospholipid, as an effective ingredient. In addition, skin-beautifying food or feed contains sphingomyelin as an effective ingredient. The present invention provides a skin beautifier and skin-beautifying food or feed supplying effects on beauty, such as skin-moisturizing and protecting effects, skin-roughness-preventing and improving effects, and a wrinkle-preventing effect, by oral ingestion thereof.

Abstract: A decoder includes a first bank and a second bank. The first bank is supplied with dynamic control from a microcomputer via a data bus, and the second bank is supplied with static control data from the data bus via the data bus. The dynamic control data or the static control data is read from an address in the bank designated by an address signal. The dynamic control data read from the first bank and second bank is transferred to one of a plurality of registers designated by the address signal.

Abstract: During adjustment of a white balance, images having different white balances are displayed respectively on a plurality of regions on the screen 201 of the display 200, based on the red video signal Rout, the green video signal Gout and the blue video signal Bout output from the gamma correction device 30. After that, an user selects any of the plurality of regions by comparing the plurality of images having the different white balances displayed on the regions A to I on the screen 201 of the display 200 and pressing a touch panel on the screen 201. The image on the selected region is displayed on the entire screen 201 of the display 200, based on the red video signal Rout, the green video signal Gout and the blue video signal Bout output from the gamma correction device 30.

Abstract: A stable pharmaceutical preparation containing an aminobenzenesulfonic acid derivative represented by the following formula (I) known as a therapeutic agent for cardiac insufficiency: or a salt thereof, or a hydrate thereof or a solvate thereof as an active ingredient, wherein each production of substance A having a retention time of about 6.4 minutes in a high performance liquid chromatography, substance B having a retention time of about 15.6 minutes in the high performance liquid chromatography, and substance C having about 22.8 minutes in the high performance liquid chromatography is substantially suppressed, wherein said high performance liquid chromatography is performed at a controlled flow rate for elution so as to give a retention time of about 7 minutes of said active ingredient by using an ultraviolet absorptiometer at 220 nm, an octylsilylated silica gel packed column (4 mm ×250 mm) at 40° C., and a mobile phase prepared by dissolving 7.

Abstract: A decoder includes a first bank and a second bank. The first bank is supplied with dynamic control from a microcomputer via a data bus, and the second bank is supplied with static control data from the data bus via the data bus. The dynamic control data or the static control data is read from an address in the bank designated by an address signal. The dynamic control data read from the first bank and second bank is transferred to one of a plurality of registers designated by the address signal.

Abstract: A method of fabricating a thermoelectric element with a higher thermoelectric performance than that of a conventional thermoelectric element. This fabrication method includes the steps of: (a) preparing a thermoelectric material having a predetermined composition; and (b) applying extruding pressure to the thermoelectric material in a first direction to extrude it through a die having, in an area which is not less than half of a deforming area of the thermoelectric material in the first direction, a maximum strain rate within +30% of an average strain rate so as to plastically deform the thermoelectric material into an extruded product of the thermoelectric material.

Abstract: A composition with a high ganglioside content is manufactured by a method characterized in that milk or milk-derived material containing ganglioside is dispersed in an ethanol solution so that the concentration of ethanol becomes 60˜95%; after removing the precipitate which is generated by heating the solution to a temperature higher than 50° C., the obtained supernatant is cooled to a temperature lower than 0° C; and the obtained precipitate is recovered. The obtained composition with a high ganglioside content is used advantageously as a material for foods and drinks, medicines, chemical products, etc.

Abstract: A method of preparing Ganglioside G.sub.M3 which comprises converting Ganglioside G.sub.D3 into Ganglioside G.sub.M3 in an alkaline condition is disclosed. The conversion of Ganglioside G.sub.D3 into Ganglioside G.sub.M3 is preferably carried out by thermal treating Ganglioside G.sub.D3 in an alkaline condition. The thermal treatment is preferably carried out at a pH ranging from 8 to 11 and at a temperature ranging from 30.degree. C. to 140.degree. C.

Abstract: A method of preparing Ganglioside G.sub.M3 which comprises thermally treating a lipid containing material which includes Ganglioside G.sub.D3 at a temperature of from 60.degree. to 140.degree. C., for a period of from 2 to 180 minutes at a pH ranging from 6-8. The lipid containing material contains at least 10 wt % liquid and is cream or a milk product prepared from cream.